1. HOME

Biosimilars

Project Name INN Indications Clinical Info
Project NameCT-P39
INNOmalizumab
IndicationsAsthma, urticaria
Clinical InfoPhase3
Project NameCT-P41
INNDenosumab
IndicationsOsteoporosis, bone Loss
Clinical InfoPhase3
Project NameCT-P42
INNAflibercept
IndicationsDiabetic macular edema
Clinical InfoPhase3
Project NameCT-P43
INNUstekinumab
IndicationsPsoriasis, Crohn's disease
Clinical InfoPhase3
Project NameCT-P47
INNTocilizumab
IndicationsRheumatoid arthritis
Clinical InfoPhase3
Project NameCT-P53
INNOcrelizumab
IndicationsMultiple sclerosis
Clinical InfoPhase3

It is not intended for product promotion or sales. For more information, contact your doctor or healthcare professional.